Loading…

Characterization of virulence gene distribution and antibiotic susceptibility profiles of diarrheagenic Escherichia coli from chicken faeces

The inappropriate use of antibiotics in the poultry industry for prophylaxis and growth promotion has contributed to the development and spread of antibiotic resistance in zoonotic pathogens. This study aimed to understand the prevalence of pathogenic Escherichia coli (E. coli) in chicken faeces and...

Full description

Saved in:
Bibliographic Details
Published in:Journal of advanced biotechnology and experimental therapeutics 2022, Vol.5 (1), p.148-162
Main Authors: Giri, Shobha, Kumar, Sanath, K, Girisha, Shetty, Veena
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The inappropriate use of antibiotics in the poultry industry for prophylaxis and growth promotion has contributed to the development and spread of antibiotic resistance in zoonotic pathogens. This study aimed to understand the prevalence of pathogenic Escherichia coli (E. coli) in chicken faeces and their antibiotic susceptibility profiles. Forty-five E. coli isolated from the chicken faeces were further tested for virulence genes associated with diarrheagenic E. coli and extended-spectrum β-lactamase (ESBL) genes blaCTX, blaTEM, blaSHV and Metallo-beta-lactamase gene blaNDM. Results showed that eaeA and astA genes were detected in 60% of the isolates, followed by bfpA in 57.8 %, lt in 26.7% and st gene in 2.2% of the isolates. Further, 15.5% of the isolates produced ESBL phenotypically whereas genotypically, one isolate was positive for blaCTX, one for blaTEM, and one for the blaSHV gene. Twelve isolates (26.7%) harboured gene blaNDM. High levels of resistance were observed against cefepime (93.3%), ertapenem (78.9%), meropenem (73.6%), tetracycline (88.9%), and cotrimoxazole (75.6%). The study highlights the importance of poultry as a source of human pathogenic multidrug-resistant (MDR) E. coli and their environmental dissemination. [ J Adv Biotechnol Exp Ther 2022; 5(1.000): 148-162]
ISSN:2616-4760
2616-4760
DOI:10.5455/jabet.2022.d104